Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Syntara Limited has requested a trading halt for its ordinary shares pending an announcement regarding a capital raising placement to institutional and sophisticated investors. The halt will remain in effect until normal trading resumes or the announcement is made, whichever comes first. The company confirms it is unaware of any reasons why the trading halt should not be granted.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-667
In the deck
Earlier from Syntara
- Response to ASX Price Query
- Pause in Trading
- Appendix 4E and Annual Report to shareholders
- Half Yearly Report and Accounts
- PXS Company Restructure Sale of Mannitol Business
Later from Syntara
- Presentation: Phase 2 study of SNT-5505 in myelofibrosis
- Interim data in Phase 2 study of SNT-5505 in myelofibrosis
- Equity Raising Presentation
- Placement
- Acceleration of skin scarring program
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara